LKC Technologies introduces RETeval

Article

LKC Technologies recently debuted RETeval, a handheld diabetic retinopathy (DR) screening device that enables any healthcare provider to screen for and detect sight-threatening DR.

Gaithersburg, MD-LKC Technologies recently debuted RETeval, a handheld diabetic retinopathy (DR) screening device that enables any healthcare provider to screen for and detect sight-threatening DR. The World Health Organization estimates more than 75% of people who have diabetes for more than 20 years will have some form of DR. The Centers for Disease Control estimates that better DR detection can reduce blindness by up to 50%-60%.

RETeval is a functional test of the retina to assess the ischemic level of the retina, which, based upon published literature, correlates well to DR and other ischemic diseases such as central retinal vein occlusion, birdshot retinopathy, and others. RETeval is fast, easy to use, and provides immediate results at a very low cost without dilation.

LKC believes that any healthcare provider, from physicians’ offices to community clinics to mobile clinics in third-world countries, could easily use the RETeval and be highly effective in alerting patients to their risk of diabetic retinopathy.

The RETeval is CE marked and approved in Canada and Japan, and is being used in a number of countries such as Indonesia, Malaysia, Japan, and the U.K. LKC is developing the clinical data necessary to submit for FDA approval in the United States. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.